AHR vs DOC vs WELL vs VTR

For growth investors, Welltower Inc.

(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus 4. 5% for Healthpeak Properties, Inc. (DOC). American Healthcare REIT, Inc. (AHR) offers the better valuation at 118. 1x trailing P/E (66. 0x forward), making it the more compelling value choice. Analysts rate American Healthcare REIT, Inc. (AHR) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, American Healthcare REIT, Inc.

(AHR) is the cheapest at 118. 1x versus Healthpeak Properties, Inc. at 196. 6x. On forward P/E, American Healthcare REIT, Inc. is actually cheaper at 66. 0x.

Over the past 5 years, American Healthcare REIT, Inc.

(AHR) delivered a total return of +292. 2%, compared to -15. 5% for Healthpeak Properties, Inc. (DOC). Over 10 years, the gap is even starker: AHR returned +292. 2% versus DOC's +11. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Ventas, Inc.

(VTR) is the lower-risk stock at 0. 01β versus Healthpeak Properties, Inc. 's 0. 52β — meaning DOC is approximately 5359% more volatile than VTR relative to the S&P 500. On balance sheet safety, American Healthcare REIT, Inc. (AHR) carries a lower debt/equity ratio of 47% versus 126% for Healthpeak Properties, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Welltower Inc.

(WELL) is pulling ahead at 35. 8% versus 4. 5% for Healthpeak Properties, Inc. (DOC). On earnings-per-share growth, the picture is similar: American Healthcare REIT, Inc. grew EPS 244. 8% year-over-year, compared to -72. 2% for Healthpeak Properties, Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Welltower Inc.

(WELL) is the more profitable company, earning 8. 8% net margin versus 2. 5% for Healthpeak Properties, Inc. — meaning it keeps 8. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DOC leads at 19. 3% versus 3. 3% for WELL. At the gross margin level — before operating expenses — WELL leads at 39. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, American Healthcare REIT, Inc.

(AHR) trades at 66. 0x forward P/E versus 118. 0x for Ventas, Inc. — 52. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AHR: 14. 4% to $56. 75.

All stocks in this comparison pay dividends.

Healthpeak Properties, Inc. (DOC) offers the highest yield at 6. 2%, versus 1. 3% for Welltower Inc. (WELL).

For long-horizon retirement investors, Ventas, Inc.

(VTR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 01), 2. 1% yield). Both have compounded well over 10 years (VTR: +65. 0%, DOC: +11. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: AHR is a small-cap quality compounder stock; DOC is a mid-cap income-oriented stock; WELL is a mid-cap high-growth stock; VTR is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.